Sponsored by
Latest
Topics
Topics
Accounting & Tax
Corporate Finance
Human Capital
Risk & Compliance
Strategy
Technology
Featured
Auditing
The Big Four Continue to Dominate Auditing: Weekly Stat
The audit market is most concentrated among the population of large accelerated filers, 88% of which tap a Big Four firm for assurance.
By
Vincent Ryan
| June 29, 2022
Read More
Resources
CFO Live
Sign Up
Menu
Topics
Accounting & Tax
Corporate Finance
Human Capital
Risk & Compliance
Strategy
Technology
Explore
Search
Latest
Resources
CFO Live
Sign Up
Sponsored by
Gilead
Strategy
Gilead to Invest $5B in Galapagos Partnership
The deal expands Gilead's investment in the European biotech as it seeks to add assets to its drug portfolio.
By
Matthew Heller
| July 15, 2019
Read More
Strategy
Allergan Bets on Tobira’s Liver Disease Drug
The Botox maker will pay up to $1.7 billion for Tobira, the developer of an experimental treatment for a nonalcoholic fatty liver condition.
By
Matthew Heller
| September 20, 2016
Read More
Risk & Compliance
SEC Charges CPA, 4 Others With Insider Trading
The defendants allegedly made $234,000 by trading in Pharmasset shares based on nonpublic information about a takeover offer.
By
Matthew Heller
| September 28, 2015
Read More
